Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 EP968 | DOI: 10.1530/endoabs.99.EP968

ECE2024 Eposter Presentations Thyroid (198 abstracts)

Experience of using tocilizumab for the treatment of glucocorticoid-resistant graves orbitopathy

Tatsiana Mokhort 1 , Volha Shyshko 2 , Kseniya Palavinkina 2 , Alena Mokhort 1 & Natalya Likhorad 3


1Belarusian State Medical University, Endocrinology, Minsk, Belarus; 2Minsk City Clinical Endocrinological Center, Minsk, Belarus; 31th City Clinical Hospital, Endocrinology, Minsk, Belarus


Objective: to evaluate the efficacy of tocilizumab (TZM) in the treatment of glucocorticoid-resistant Grave’s orbitopathy (GO).

Materials and Methods: 3 patients with GO on the background of compensated Graves’ disease were observed. Treatment of GO was initiated with methylprednisolone (total doses of 8, 000-13, 1 mg) without significant clinical effect with a CAS of 4 points. After that TZM was administered three times intravenously once a month at a dose of 8 mg / kg.

Results: The table shows the results of the initial CAS values (1) and the results of the examination 1 month after the end of therapy (2). We registered decrease of GO severity: reduction of proptosis, ophthalmotonus depletion and involution of thickness of oculomotor muscles. All patients noted a significant improvement in their quality of life, but 2 patients had minor leukopenia.

Table 1: Summary of Analytical Results
SymptomsPatient 1Patient 2Patient 3
121212
Spontaneous retrobulbar pain1-1-1-
Pain on attempted upward gaze when moving the eyeballs up or to1-1-1-
Redness of the eyelids--1---
Redness of conjunctiva1-1---
Swelling of the eyelids1-111-
Inflammation of the caruncle and/or fold1-1-1-
Swelling of conjunctiva (chemosis)1-1---
Total607140

Conclusion: TZM has been shown to be effective in reducing CAS in patients with glucocorticoid-resistant GO, so it can be used to reduce the inflammatory process and severity in patients with GO.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.